Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find attached the confirmation certificate issues by RTA for the quarter ended 30th September, 2026. You are requested to kindly take the same on record and oblige. Thanking you.

PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email I d: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030. Date: 13/10/2026 To, T o, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited (MSEI) P, J. Towers, Dalal Street, Mumbai, Maharashtra-400001. Vibgyor Towers, 4+" Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, ISIN : INE730E01016 Bandra (E), Mumbai, Maharashtra-400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Submission of confirmation certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September, 2026. Dear Sir/Madam, ~ Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish the confirmation certificate issued by the Registrar and Share Transfer Agent (RTA) for the quarter ended 30% September, 2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Yours Truly, FOR PRISM iy I D ICO AND. PHARMACY LIMITED DAVENDER SINGH DIRECTOR. DIN: 09447213. PURVA SHAREGISTRY (1) PVT. LTD. (SEBI Regn. INRO000001112 Category 1 Registrars to IPO & Share Transfer Agents) GST No. 27AAACP4924D1ZO * CIN No. U67120MH1993PTC074079 9 Shiv Shakti Industrial Estate, J. R. Boricha Marg, Near Lodha Excelus, Lower Parel East, Mumbai - 400 011 Tel : 0228-8130 / 149691 49132 Email: support@purvashare.com « Web : www.purvashare.com 01/10/2026 PRISM MEDICO & PHARMACY LIMITED - INE730E01016 Dear Sir/Madam. Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 As per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby confirm that security received from the depository participants for dematerialisation during the quarter ended September, 2026, were confirmed (accepted / rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For Purva Sharegistry (India) Pvt. Ltd. DOD ben Ms. Deepali Gaonkar Compliance Officer. PRISM MEDICO & PHARMACY LIMITED - INE730E01016 - Details of Share certificates dematerialised from 01/07/2026 to 30/09/2026 FOLIO NAME OF CERTIFICA | DIST. DIST. SHARE | DEMATERIAL SHAREHOLDER TE NO. NO.(FROM) | NO.(TO) Ss ISED ON NIL NIL NIL NIL NIL NIL NIL